CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Disatnik, M. H.
Right arrow Articles by Arteaga, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Disatnik, M. H.
Right arrow Articles by Arteaga, C. L.

Cell Growth & Differentiation, Vol 5, Issue 8 873-880, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Distinct responses of protein kinase C isozymes to c-erbB-2 activation in SKBR-3 human breast carcinoma cells

MH Disatnik, AR Winnier, D Mochly-Rosen and CL Arteaga
Department of Molecular Pharmacology, Stanford University, California 94305-5332.

We have studied the effect of activation of the c-erbB-2 receptor tyrosine kinase on protein kinase C (PKC) in cultured SKBR-3 human breast cancer cells. Treatment with the agonistic anti-receptor monoclonal antibody TAb 250 induces receptor autophosphorylation and stimulates phospholipase C-gamma 1 (L. K. Shawver et al. Cancer Res., 54: 1367-1373, 1994). TAb 250 induced a rapid and marked translocation of PKC histone phosphorylation activity to the particulate fraction of SKBR-3 cells. By immunoblot, however, this translocation was limited to specific PKC isozymes. beta PKC and zeta PKC translocated to the particulate fraction, whereas epsilon PKC underwent "partial reversed translocation" to the cell soluble fraction after receptor stimulation. Furthermore, beta PKC was rapidly degraded following TAb 250 treatment. By immunocytochemistry, beta IPKC translocated from the perinuclear area to the cytosol and into the nucleus, whereas zeta PKC translocated to the perinuclear region and into the nucleus. Consistent with the Western blot results, epsilon PKC translocated from the nucleus to the perinuclear area and the cytosol. These changes in the localization of PKC isozymes were not observed after addition of normal IgG1 or a nonagonistic anti-c-erbB-2 monoclonal antibody to SKBR-3 cells. alpha, beta II, or delta PKC present in these cells did not translocate following receptor stimulation. These data indicate that c-erbB-2 signal transduction may involve the activation of specific PKC isozymes. The biological role of these enzymes in the phenotype and cellular responses of c-erbB-2-overexpressing carcinoma cells remains to be studied.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. Pandya, D. Wyatt, B. Gallagher, D. Shah, A. Baker, J. Bloodworth, A. Zlobin, A. Pannuti, A. Green, I. O. Ellis, et al.
PKC{alpha} Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance
Clin. Cancer Res., January 1, 2016; 22(1): 175 - 186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Y. C. Chow, H. Dong, K. T. Quach, P. N. Van Nguyen, K. Chen, and J. M. Carethers
TGF-{beta} mediates PTEN suppression and cell motility through calcium-dependent PKC-{alpha} activation in pancreatic cancer cells
Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G899 - G905.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
P. Acs, K. Bogi, P. S. Lorenzo, A. M. Marquez, T. Biro, Z. Szallasi, and P. M. Blumberg
The Catalytic Domain of Protein Kinase C Chimeras Modulates the Affinity and Targeting of Phorbol Ester-induced Translocation
J. Biol. Chem., August 29, 1997; 272(35): 22148 - 22153.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Yedovitzky, D. Mochly-Rosen, J. A. Johnson, M. O. Gray, D. Ron, E. Abramovitch, E. Cerasi, and R. Nesher
Translocation Inhibitors Define Specificity of Protein Kinase C Isoenzymes in Pancreatic {beta}-Cells
J. Biol. Chem., January 17, 1997; 272(3): 1417 - 1420.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
D. Ron, J. Luo, and D. Mochly-Rosen
C2 Region-derived Peptides Inhibit Translocation and Function of {beta} Protein Kinase C in Vivo
J. Biol. Chem., October 13, 1995; 270(41): 24180 - 24187.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D Mochly-Rosen
Localization of protein kinases by anchoring proteins: a theme in signal transduction
Science, April 14, 1995; 268(5208): 247 - 251.
[Abstract] [PDF]


Home page
Circ. Res.Home page
J. A. Johnson and D. Mochly-Rosen
Inhibition of the Spontaneous Rate of Contraction of Neonatal Cardiac Myocytes by Protein Kinase C Isozymes : A Putative Role for the {varepsilon} Isozyme
Circ. Res., April 1, 1995; 76(4): 654 - 663.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.